A Szallasi

Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules).

P. Blumberg, A. Szallasi, P M Blumberg, 1993, Advances in pharmacology.

Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor.

P. Blumberg, A. Szallasi, P M Blumberg, 1990, Life sciences.

Molecular target size of the vanilloid (capsaicin) receptor in pig dorsal root ganglia.

P. Blumberg, A. Szallasi, P M Blumberg, 1991, Life sciences.

Vanilloid (Capsaicin) receptors and mechanisms.

P. Blumberg, A. Szallasi, P M Blumberg, 1999, Pharmacological reviews.

Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.

P. Gimotty, M. Wasik, A. Szallasi, 2006, Leukemia research.

The vanilloid (capsaicin) receptor: receptor types and species differences.

A. Szallasi, A Szallasi, 1994, General pharmacology.

Competitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.

C. Goso, P. Blumberg, A. Szallasi, 1993, The Journal of pharmacology and experimental therapeutics.